Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Adverse effects of pertussis and rubella vaccines [[electronic resource] ] : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / Christopher P. Howson, Cynthia J. Howe, and Harvey V. Fineberg, editors
| Adverse effects of pertussis and rubella vaccines [[electronic resource] ] : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / Christopher P. Howson, Cynthia J. Howe, and Harvey V. Fineberg, editors |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1991 |
| Descrizione fisica | 1 online resource (xii, 367 pages) : illustrations |
| Disciplina | 615/.372 |
| Altri autori (Persone) |
HowsonChristopher Paul
HoweCynthia J FinebergHarvey V |
| Soggetto topico |
Pertussis vaccines - Side effects
Rubella vaccines - Side effects Whooping cough - Vaccination - Complications Rubella - Vaccination - Complications |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-20370-6
9786610203703 0-309-55597-3 0-585-03433-8 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910456250803321 |
| Washington, D.C., : National Academy Press, 1991 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Adverse effects of pertussis and rubella vaccines : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / editors, Christopher P. Howson, Cynthia J. Howe, Harvey V. Fineberg
| Adverse effects of pertussis and rubella vaccines : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / editors, Christopher P. Howson, Cynthia J. Howe, Harvey V. Fineberg |
| Pubbl/distr/stampa | Washington, D.C. : , : National Academy Press, , 1991 |
| Descrizione fisica | 1 online resource (xii, 367 pages) : illustrations |
| Disciplina | 615/.372 |
| Altri autori (Persone) |
HowsonChristopher Paul
HoweCynthia J FinebergHarvey V |
| Soggetto topico |
Pertussis vaccines - Side effects
Rubella vaccines - Side effects Whooping cough - Vaccination - Complications Rubella - Vaccination - Complications |
| ISBN |
1-280-20370-6
9786610203703 0-309-55597-3 0-585-03433-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910778503103321 |
| Washington, D.C. : , : National Academy Press, , 1991 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Adverse effects of pertussis and rubella vaccines : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / Christopher P. Howson, Cynthia J. Howe, and Harvey V. Fineberg, editors
| Adverse effects of pertussis and rubella vaccines : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / Christopher P. Howson, Cynthia J. Howe, and Harvey V. Fineberg, editors |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1991 |
| Descrizione fisica | 1 online resource (xii, 367 pages) : illustrations |
| Disciplina | 615/.372 |
| Altri autori (Persone) |
HowsonChristopher Paul
HoweCynthia J FinebergHarvey V |
| Soggetto topico |
Pertussis vaccines - Side effects
Rubella vaccines - Side effects Whooping cough - Vaccination - Complications Rubella - Vaccination - Complications Pertussis Vaccine - adverse effects Rubella Vaccine - adverse effects |
| Soggetto genere / forma | Congress |
| ISBN |
9786610203703
9781280203701 1280203706 9780309555975 0309555973 9780585034331 0585034338 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Adverse Effects of Pertussis and Rubella Vaccines -- Copyright -- Preface -- Acknowledgments -- Contents -- Adverse Effects of PERTUSSIS and RUBELLA Vaccines -- 1 Executive Summary -- METHODOLOGIC CONSIDERATIONS IN EVALUATING THE EVIDENCE -- SUMMARY AND CONCLUSIONS -- RESEARCH NEEDS -- 2 Histories of Pertussis and Rubella Vaccines -- PERTUSSIS VACCINES -- Epidemiology of Whooping Cough -- Clinical Description -- Diagnosis -- Complications -- Descriptive Epidemiology -- Nature of the Causative Organism, B. pertussis -- Major Milestones in the Development of Pertussis Vaccines -- Whole-Cell Vaccines -- Acellular Vaccines -- Brief History of the Controversy Pertaining to Adverse Events Following Pertussis Vaccination -- RUBELLA VACCINES -- Epidemiology of the Disease Rubella -- Clinical Description -- Diagnosis -- Complications -- Descriptive Epidemiology -- Nature of the Rubella Virus -- Major Milestones in the Development of Rubella Vaccines -- Brief History of the Controversy Pertaining to Adverse Events Following Rubella Vaccination -- REFERENCES -- 3 Methodologic Considerations in Evaluating the Evidence -- THE NATURE OF THE EVIDENCE -- QUESTIONS TO BE ADDRESSED -- (1) Can vaccine cause the adverse event? -- (2) How frequently does vaccine cause the event? -- (3) Did vaccination cause a particular case of the adverse event? -- THE BURDEN OF PROOF -- CATEGORIES OF EVIDENCE -- Experiments in Humans -- Randomized Controlled Trials -- Other Experimental Studies -- Experiments in Animals: Animal Models -- Controlled Epidemiologic Studies (Observational) -- Cohort Studies -- Case-Comparison Studies -- Other Controlled Studies -- Case Reports and Case Series -- Searching for Patterns -- Historical Comparisons -- Causation of the Individual Case -- Monitoring System for Adverse Events Following Immunization -- ASSESSMENT OF THE EVIDENCE.
Evaluation of Single Studies -- Integration of the Collective Results -- Meta-Analysis -- Considerations in Inferring Causality -- THE NATURE OF THE CONCLUSIONS -- Quantitation -- Resolution -- Uncertainty and Confidence -- Quality -- Comprehensiveness -- Neutrality -- Judgment -- SUMMARY OF THE EVIDENCE -- REFERENCES -- 4 Evidence Concerning Pertussis Vaccines and Central Nervous System Disorders, Including Infantile... -- INFANTILE SPASMS -- Clinical Description -- Descriptive Epidemiology -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusion -- HYPSARRHYTHMIA -- Clinical Description -- Descriptive Epidemiology -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusion -- ASEPTIC MENINGITIS -- Clinical Description -- Descriptive Epidemiology -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusion -- ENCEPHALOPATHY -- Clinical Description -- Encephalopathy Following Whooping Cough -- Pathology -- Descriptive Epidemiology -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Case Series -- Studies in Defined Populations -- The National Childhood Encephalopathy Study -- Other Controlled Studies in Humans -- Evidence from Studies in Animals -- Aluminum Salts -- Summary -- Conclusion -- REFERENCES -- 5 Evidence Concerning Pertussis Vaccines and Deaths Classified as Sudden Infant Death Syndrome -- CLINICAL DESCRIPTION, DIAGNOSIS, AND PATHOLOGY -- DESCRIPTIVE EPIDEMIOLOGY. HISTORY OF SUSPECTED ASSOCIATION WITH PERTUSSIS VACCINES -- EVIDENCE FROM STUDIES IN HUMANS -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- SUMMARY -- CONCLUSION -- REFERENCES -- 6 Evidence Concerning Pertussis Vaccines and Other Illnesses and Conditions -- ANAPHYLAXIS -- Clinical Description and Pathologic Aspects -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Controlled Epidemiologic Studies -- Evidence from Studies in Animals -- Endotoxin -- Summary -- Conclusion -- AUTISM -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Summary -- Conclusion -- ERYTHEMA MULTIFORME OR OTHER RASH -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Aluminum Salts -- Summary -- Conclusion -- GUILLAIN-BARRÉ SYNDROME (POLYNEUROPATHY) -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Summary -- Conclusion -- PERIPHERAL MONONEUROPATHY -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Summary -- Conclusion -- HEMOLYTIC ANEMIA -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Summary -- Conclusion -- JUVENILE DIABETES -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Controlled Epidemiologic Study -- Case Report -- Evidence from Studies in Animals -- Summary -- Conclusion -- LEARNING DISABILITIES AND HYPERACTIVITY -- Clinical Description -- Learning Disability, Reading Disability, and Dyslexia -- Hyperactivity, Hyperkinesis, and Attention Deficit Disorder -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Controlled Epidemiologic Studies -- Summary. Conclusion -- PROTRACTED INCONSOLABLE CRYING AND SCREAMING -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusions -- REYE SYNDROME -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Controlled Epidemiologic Study -- Case Reports and Case Series -- Summary -- Conclusion -- SHOCK AND ''UNUSUAL SHOCK-LIKE STATE" WITH HYPOTONICITY, HYPORESPONSIVENESS, AND SHORT-LIVED CONVULS ... -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusion -- THROMBOCYTOPENIA -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports and Case Series -- Summary -- Conclusion -- REFERENCES -- 7 Evidence Concerning Rubella Vaccines and Arthritis, Radiculoneuritis, and Thrombocytopenic Purpura -- ARTHRITIS -- Clinical Description and Pathologic Aspects -- Descriptive Epidemiology -- History of an Association with Rubella Vaccines -- Evidence from Studies in Humans -- Acute Arthropathy and Arthritis -- Chronic Arthritis -- Evidence from Studies in Animals -- Possible Mechanisms -- Summary -- Acute Arthropathy and Arthritis -- Chronic Arthritis -- Conclusions -- RADICULONEURITIS AND OTHER NEUROPATHIES -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports and Case Series -- Summary -- Conclusion -- THROMBOCYTOPENIC PURPURA -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Summary -- Conclusion -- REFERENCES -- Afterword on Research Needs -- Bibliography -- Glossary of Terms B -- Appendixes. A Strategies For Gathering Information: Adverse Effects of Pertussis and Rubella Vaccines -- LITERATURE SEARCHES -- Electronic Data Bases -- OTHER SOURCES -- Reference Lists -- Presentations -- Public Meeting (January 10, 1990) -- Workshop (May 14, 1990) -- Committee Meeting (May 15, 1990) -- Additional Individuals and Organizations Who Provided Information -- Review of Interim Bibliography -- ABSTRACTION OF DATA FROM CASE REPORTS, CASE SERIES, AND CONTROLLED STUDIES -- Rationale -- Procedures for Abstraction and Adjudication of Study Data -- B Pertussis and Rubella Vaccines: A Brief Chronology -- PERTUSSIS VACCINES -- RUBELLA VACCINES -- REFERENCES -- C Animal Models for the Study of Whooping Cough and the Testing of Vaccine Materials -- ANIMAL MODELS FOR THE STUDY OF WHOOPING COUGH -- STANDARDIZED ANIMAL TESTS OF VACCINE MATERIALS -- REFERENCES -- D Technical Details of Power Calculations and Meta-Analyses -- POWER CALCULATIONS -- META-ANALYSES -- Formal Analysis -- Informal Analysis -- REFERENCES -- E Possible Involvement of Aluminum Salts in Erythema Multiforme, Encephalopathy, or Other Adverse E ... -- REFERENCES -- F Committee and Staff Biographies -- COMMITTEE -- STAFF -- Index. |
| Record Nr. | UNINA-9910965570303321 |
| Washington, D.C., : National Academy Press, 1991 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
AIDS vaccines, HIV receptors, and AIDS research [[electronic resource] /] / Lawrence B. Kendow, editor
| AIDS vaccines, HIV receptors, and AIDS research [[electronic resource] /] / Lawrence B. Kendow, editor |
| Pubbl/distr/stampa | New York, : Nova Biomedical Books, c2008 |
| Descrizione fisica | 1 online resource (358 p.) |
| Disciplina | 615/.372 |
| Altri autori (Persone) | KendowLawrence B |
| Soggetto topico |
AIDS vaccines
HIV (Viruses) |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-60876-480-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""AIDS VACCINES, HIV RECEPTORS, AND AIDS RESEARCH""; ""CONTENTS""; ""PREFACE""; ""Chapter 1 SAFE AND EFFECTIVE HIV VACCINES SINCE 1999 ""; ""ABSTRACT ""; ""INTRODUCTION""; ""SOME PRE-1984 VACCINES FOR HUMAN USE ""; ""Plague ""; ""Variolation ""; ""Edward Jenner�s Smallpox Vaccine""; ""Louis Pasteur�s Vaccines""; ""Polio Vaccines""; ""THE NORMAL HUMAN IMMUNE RESPONSE""; ""THE WORST PANDEMIC IN HISTORY, HIV/AIDS""; ""The First Announcement of the Isolation of the Causative Agent of AIDS ""; ""The Natural History of HIV Infection in Man""
""Ethical Considerations in HIV Preventive Vaccine Research """"THE AUTHOR�S APPROACH TO HIV VACCINES DEVELOPMENT""; ""A General Surgeon Involved with HIV Vaccines Research and Development? ""; ""What is Cure of HIV Infection?""; ""The Stepping Stone for HIV Preventive Vaccines Development""; ""Not all Medical Remedies Require Registration before use on Patients""; ""Possible Appropriate Immunogens for a Candidate HIV Therapeutic Vaccine""; ""Confirmation of the Safety of the Candidate Autogenous HIV Therapeutic Vaccine""; ""Efficacy Trials of the Safe Candidate HIV Therapeutic Vaccine"" ""Proceeding to the HIV Preventive Vaccine """"Modifications to the Initial Vaccines and Dosage Regimen""; ""THE VACCINES ON LARGER POPULATIONS""; ""VEHEMENT RESISTANCE TO ATTEMPTS TO LOCK UP OUR HIV VACCINES""; ""CONCLUSION""; ""APPENDICES""; ""REFERENCES ""; ""Chapter 2 AIDS: A MUCOSAL APPROACH TO A MUCOSAL INFECTION ""; ""ABSTRACT""; ""INTRODUCTION""; ""Mucosal Transmission and HIV Receptors""; ""Correlates of Protection; LTNPs, Elite Controllers and Natural Hosts ""; ""TARGETING THE MUCOSAL IMMUNE SYSTEM""; ""Mucosal Adjuvants ""; ""Innate Immunity and Antiviral Factors "" ""Early Experiments Revisited � Xeno and Allo-Immunity in HIV Protection """"SUMMARY ""; ""REFERENCES""; ""Chapter 3 TRANSMISSION OF HIV FROM DENDRITIC CELLS TO CD4+ T CELLS: A PROMISING TARGET FOR VACCINATION AND THERAPEUTIC INTERVENTION ""; ""ABSTRACT ""; ""INTRODUCTION ""; ""1. Subsets of DCs and Susceptibility to HIV Infection""; ""2. Restriction of HIV-1 Replication in DCs""; ""3. HIV Transmission from DC to T cells: trans vs. cis Infection""; ""4. How to Achieve Immune Protection: Future Directions ""; ""CONCLUSION ""; ""ACKNOWLEDGEMENTS ""; ""REFERENCES "" ""Chapter 4 THE GLOBALIZATION-AIDS-POVERTY SYNDROME IN AFRICA1 """"INTRODUCTION ""; ""NEOLIBERALIZM AND AIDS IN CONTEXT ""; ""COLONIALISM, GENDER, AND THE GEOGRAPHY OF HIV""; ""THE LIBERALIZATION OF AIDS: GLOBALIZATION AND POVERTY""; ""MAKING THE LINKS: GENDER, DEEPENING POVERTY AND AIDS""; ""BREAKING THE GAPS""; ""REFERENCES ""; ""Chapter 5 YOUTH SEXUALITY IN THE CONTEXT OF HIV/AIDS IN SOUTH AFRICA ""; ""ABSTRACT""; ""1. INTRODUCTION ""; ""Socialization""; ""Sexual Relations""; ""Sexuality Research and HIV""; ""Culture and Sexuality""; ""Sociohistorical Context ""; ""2. METHODOLOGY"" ""Sample and Procedure"" |
| Record Nr. | UNINA-9910452187603321 |
| New York, : Nova Biomedical Books, c2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
AIDS vaccines, HIV receptors, and AIDS research [[electronic resource] /] / Lawrence B. Kendow, editor
| AIDS vaccines, HIV receptors, and AIDS research [[electronic resource] /] / Lawrence B. Kendow, editor |
| Pubbl/distr/stampa | New York, : Nova Biomedical Books, c2008 |
| Descrizione fisica | 1 online resource (358 p.) |
| Disciplina | 615/.372 |
| Altri autori (Persone) | KendowLawrence B |
| Soggetto topico |
AIDS vaccines
HIV (Viruses) |
| ISBN | 1-60876-480-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Contents -- Preface -- Chapter 1 Safe And Effective HIV Vaccines Since 1999 -- Chapter 2 AIDS: A Mucosal Approach To A Mucosal Infection -- Chapter 3 Transmission Of HIV From Dendritic Cells To CD4+ T Cells: A Promising Target For Vaccination And Therapeutic Intervention -- Chapter 4 The Globalization-AIDS-Poverty Syndrome In Africa1 -- Chapter 5 Youth Sexuality in the Context Of HIV/AIDS In South Africa -- Chapter 6 Vitamin E in the context of HIV disease: current knowledge and perspectives -- Chapter 7 CCR5 gene expression and polymorphism as potential prognostic markers of the outcome of allogeneic hematopoietic stem cell transplantation --- Chapter 8 Emerging roles of SDF-1α -CXCR4 axis in vertebrate development -- Index. |
| Record Nr. | UNINA-9910779517503321 |
| New York, : Nova Biomedical Books, c2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Concepts in vaccine development / / editor, Stefan H.E. Kaufmann
| Concepts in vaccine development / / editor, Stefan H.E. Kaufmann |
| Edizione | [Reprint 2012] |
| Pubbl/distr/stampa | Berlin ; ; New York : , : Walter de Gruyter, , 1996 |
| Descrizione fisica | 1 online resource (605 pages) : illustrations |
| Disciplina | 615/.372 |
| Altri autori (Persone) | KaufmannS. H. E (Stefan H. E.) |
| Soggetto topico |
Vaccines
Immunization |
| Soggetto genere / forma | Electronic books. |
| ISBN | 3-11-090666-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Front matter -- Preface -- Bicentennial of the first vaccination by Edward Jenner / Kaufmann, Stefan H.E. -- Contents -- 1. The Need for New Vaccines -- 1.1. Vaccines as Evolutionary Tools: The Virulence-Antigen Strategy / Ewald, Paul W. -- 1.2. Economic Perspectives on Vaccine Needs / Ashley, Robert V. / Murray, Christopher J. L. -- 1.3. Future Immunization Strategies - Considerations from the Public Health View / Dittmann, Sieghart -- 1.4. The New Pertussis Vaccines / Klein, David L. / Heilman, Carole -- 2. General Principles of Immunology -- 2.1. Basic Principles of Immunity Against Intracellular Bacteria and Protozoa / Szalay, Gudrun / Kaufmann, Stefan H. E. -- 2.2. Viral Immunity and Vaccine Strategies / Woodland, David L. / Cole, Geoffrey A. / Doherty, Peter C. -- 2.3. Broadly Reactive HLA Restricted Τ Cell Epitopes and Their Implications for Vaccine Design / Sidney, John / Kubo, Ralph T. / Wentworth, Peggy A. / Alexander, Jeff / Chesnut, Robert W. / Grey, Howard M. / Sette, Alessandro -- 2.4. Quantitative Considerations in the Design of Vaccination Strategies Against Pathogens Uniquely Susceptible to Cell-Mediated Attack / Bretscher, Peter -- 2.5. The Impact of the Type 1 and Type 2 Τ Helper Cell Concept on Novel Vaccine Design with Emphasis on Protection Against Leishmania Parasites / Bogdan, Christian / Röllinghoff, Martin -- 3. General Principles of Vaccinology -- 3.1. Modern Adjuvants. Functional Aspects / Morein, Bror / Lövgren-Bengtsson, Karin / Cox, John -- 3.2. Biodegradable Microspheres as Vehicles for Antigens / Kersten, Gideon F.A. / Gander, Bruno -- 3.3. Peptide Based Vaccines / Schild, Hansjörg / Rammensee, Hans-Georg -- 3.4. Recombinant Bacteria as Vaccine Carriers of Heterologous Antigens / Hormaeche, Carlos E. / Khan, C. M. Anjam -- 3.5. Genetic Detoxification of Bacterial Toxins / Rappuoli, Rino / Pizza, Mariagrazia -- 3.6. Recombinant Virus as Vaccination Carrier of Heterologous Antigens / Perkus, Marion E. / Paoletti, Enzo -- 3.7. Naked DNA Vaccination / Shiver, John W. / Ulmer, Jeffrey B. / Donnelly, John J. / Liu, Margaret A. -- 3.8. Oral Vaccination, Mucosal Immunity and Oral Tolerance with Special Reference to Cholera Toxin / Holmgren, Jan / Czerkinsky, Cecil / Sun, Jia-Bin / Svennerholm, Ann-Mari -- 4. Specific Vaccination Strategies -- 4.1. Helicobacter pylori: Pathogenic Determinants and Strategies for Vaccine Design / Ghiara, Paolo / Covacci, Antonello / Telford, John L. / Rappuoli, Rino -- 4.2. Malaria Vaccination / Patarroyo, Manuel E. / Amador, Roberto -- 4.3. Vaccination Against Schistosomiasis: Concepts and Strategies / Riveau, Gilles J. / Capron, André -- 4.4. AIDS Vaccination / Norley, Stephen / Kurth, Reinhard -- 4.5. Vaccination Therapy Against Autoimmune Diseases / Cohen, Irun R. / Mor, Felix -- Contributors -- Index |
| Record Nr. | UNINA-9910464158903321 |
| Berlin ; ; New York : , : Walter de Gruyter, , 1996 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Concepts in vaccine development / / editor, Stefan H.E. Kaufmann
| Concepts in vaccine development / / editor, Stefan H.E. Kaufmann |
| Edizione | [Reprint 2012] |
| Pubbl/distr/stampa | Berlin ; ; New York : , : Walter de Gruyter, , 1996 |
| Descrizione fisica | 1 online resource (605 pages) : illustrations |
| Disciplina | 615/.372 |
| Altri autori (Persone) | KaufmannS. H. E (Stefan H. E.) |
| Soggetto topico |
Vaccines
Immunization |
| ISBN | 3-11-090666-X |
| Classificazione | XD 3300 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Front matter -- Preface -- Bicentennial of the first vaccination by Edward Jenner / Kaufmann, Stefan H.E. -- Contents -- 1. The Need for New Vaccines -- 1.1. Vaccines as Evolutionary Tools: The Virulence-Antigen Strategy / Ewald, Paul W. -- 1.2. Economic Perspectives on Vaccine Needs / Ashley, Robert V. / Murray, Christopher J. L. -- 1.3. Future Immunization Strategies - Considerations from the Public Health View / Dittmann, Sieghart -- 1.4. The New Pertussis Vaccines / Klein, David L. / Heilman, Carole -- 2. General Principles of Immunology -- 2.1. Basic Principles of Immunity Against Intracellular Bacteria and Protozoa / Szalay, Gudrun / Kaufmann, Stefan H. E. -- 2.2. Viral Immunity and Vaccine Strategies / Woodland, David L. / Cole, Geoffrey A. / Doherty, Peter C. -- 2.3. Broadly Reactive HLA Restricted Τ Cell Epitopes and Their Implications for Vaccine Design / Sidney, John / Kubo, Ralph T. / Wentworth, Peggy A. / Alexander, Jeff / Chesnut, Robert W. / Grey, Howard M. / Sette, Alessandro -- 2.4. Quantitative Considerations in the Design of Vaccination Strategies Against Pathogens Uniquely Susceptible to Cell-Mediated Attack / Bretscher, Peter -- 2.5. The Impact of the Type 1 and Type 2 Τ Helper Cell Concept on Novel Vaccine Design with Emphasis on Protection Against Leishmania Parasites / Bogdan, Christian / Röllinghoff, Martin -- 3. General Principles of Vaccinology -- 3.1. Modern Adjuvants. Functional Aspects / Morein, Bror / Lövgren-Bengtsson, Karin / Cox, John -- 3.2. Biodegradable Microspheres as Vehicles for Antigens / Kersten, Gideon F.A. / Gander, Bruno -- 3.3. Peptide Based Vaccines / Schild, Hansjörg / Rammensee, Hans-Georg -- 3.4. Recombinant Bacteria as Vaccine Carriers of Heterologous Antigens / Hormaeche, Carlos E. / Khan, C. M. Anjam -- 3.5. Genetic Detoxification of Bacterial Toxins / Rappuoli, Rino / Pizza, Mariagrazia -- 3.6. Recombinant Virus as Vaccination Carrier of Heterologous Antigens / Perkus, Marion E. / Paoletti, Enzo -- 3.7. Naked DNA Vaccination / Shiver, John W. / Ulmer, Jeffrey B. / Donnelly, John J. / Liu, Margaret A. -- 3.8. Oral Vaccination, Mucosal Immunity and Oral Tolerance with Special Reference to Cholera Toxin / Holmgren, Jan / Czerkinsky, Cecil / Sun, Jia-Bin / Svennerholm, Ann-Mari -- 4. Specific Vaccination Strategies -- 4.1. Helicobacter pylori: Pathogenic Determinants and Strategies for Vaccine Design / Ghiara, Paolo / Covacci, Antonello / Telford, John L. / Rappuoli, Rino -- 4.2. Malaria Vaccination / Patarroyo, Manuel E. / Amador, Roberto -- 4.3. Vaccination Against Schistosomiasis: Concepts and Strategies / Riveau, Gilles J. / Capron, André -- 4.4. AIDS Vaccination / Norley, Stephen / Kurth, Reinhard -- 4.5. Vaccination Therapy Against Autoimmune Diseases / Cohen, Irun R. / Mor, Felix -- Contributors -- Index |
| Record Nr. | UNINA-9910788701803321 |
| Berlin ; ; New York : , : Walter de Gruyter, , 1996 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Concepts in vaccine development / / editor, Stefan H.E. Kaufmann
| Concepts in vaccine development / / editor, Stefan H.E. Kaufmann |
| Edizione | [Reprint 2012] |
| Pubbl/distr/stampa | Berlin ; ; New York : , : Walter de Gruyter, , 1996 |
| Descrizione fisica | 1 online resource (605 pages) : illustrations |
| Disciplina | 615/.372 |
| Altri autori (Persone) | KaufmannS. H. E (Stefan H. E.) |
| Soggetto topico |
Vaccines
Immunization |
| ISBN | 3-11-090666-X |
| Classificazione | XD 3300 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Front matter -- Preface -- Bicentennial of the first vaccination by Edward Jenner / Kaufmann, Stefan H.E. -- Contents -- 1. The Need for New Vaccines -- 1.1. Vaccines as Evolutionary Tools: The Virulence-Antigen Strategy / Ewald, Paul W. -- 1.2. Economic Perspectives on Vaccine Needs / Ashley, Robert V. / Murray, Christopher J. L. -- 1.3. Future Immunization Strategies - Considerations from the Public Health View / Dittmann, Sieghart -- 1.4. The New Pertussis Vaccines / Klein, David L. / Heilman, Carole -- 2. General Principles of Immunology -- 2.1. Basic Principles of Immunity Against Intracellular Bacteria and Protozoa / Szalay, Gudrun / Kaufmann, Stefan H. E. -- 2.2. Viral Immunity and Vaccine Strategies / Woodland, David L. / Cole, Geoffrey A. / Doherty, Peter C. -- 2.3. Broadly Reactive HLA Restricted Τ Cell Epitopes and Their Implications for Vaccine Design / Sidney, John / Kubo, Ralph T. / Wentworth, Peggy A. / Alexander, Jeff / Chesnut, Robert W. / Grey, Howard M. / Sette, Alessandro -- 2.4. Quantitative Considerations in the Design of Vaccination Strategies Against Pathogens Uniquely Susceptible to Cell-Mediated Attack / Bretscher, Peter -- 2.5. The Impact of the Type 1 and Type 2 Τ Helper Cell Concept on Novel Vaccine Design with Emphasis on Protection Against Leishmania Parasites / Bogdan, Christian / Röllinghoff, Martin -- 3. General Principles of Vaccinology -- 3.1. Modern Adjuvants. Functional Aspects / Morein, Bror / Lövgren-Bengtsson, Karin / Cox, John -- 3.2. Biodegradable Microspheres as Vehicles for Antigens / Kersten, Gideon F.A. / Gander, Bruno -- 3.3. Peptide Based Vaccines / Schild, Hansjörg / Rammensee, Hans-Georg -- 3.4. Recombinant Bacteria as Vaccine Carriers of Heterologous Antigens / Hormaeche, Carlos E. / Khan, C. M. Anjam -- 3.5. Genetic Detoxification of Bacterial Toxins / Rappuoli, Rino / Pizza, Mariagrazia -- 3.6. Recombinant Virus as Vaccination Carrier of Heterologous Antigens / Perkus, Marion E. / Paoletti, Enzo -- 3.7. Naked DNA Vaccination / Shiver, John W. / Ulmer, Jeffrey B. / Donnelly, John J. / Liu, Margaret A. -- 3.8. Oral Vaccination, Mucosal Immunity and Oral Tolerance with Special Reference to Cholera Toxin / Holmgren, Jan / Czerkinsky, Cecil / Sun, Jia-Bin / Svennerholm, Ann-Mari -- 4. Specific Vaccination Strategies -- 4.1. Helicobacter pylori: Pathogenic Determinants and Strategies for Vaccine Design / Ghiara, Paolo / Covacci, Antonello / Telford, John L. / Rappuoli, Rino -- 4.2. Malaria Vaccination / Patarroyo, Manuel E. / Amador, Roberto -- 4.3. Vaccination Against Schistosomiasis: Concepts and Strategies / Riveau, Gilles J. / Capron, André -- 4.4. AIDS Vaccination / Norley, Stephen / Kurth, Reinhard -- 4.5. Vaccination Therapy Against Autoimmune Diseases / Cohen, Irun R. / Mor, Felix -- Contributors -- Index |
| Record Nr. | UNINA-9910815140603321 |
| Berlin ; ; New York : , : Walter de Gruyter, , 1996 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Development of vaccines [[electronic resource] ] : from discovery to clinical testing / / edited by Manmohan Singh, Indresh K. Srivastava
| Development of vaccines [[electronic resource] ] : from discovery to clinical testing / / edited by Manmohan Singh, Indresh K. Srivastava |
| Pubbl/distr/stampa | Hoboken, N.J., : John Wiley & Sons, c2011 |
| Descrizione fisica | 1 online resource (478 p.) |
| Disciplina | 615/.372 |
| Altri autori (Persone) |
Manmohan Singh <1964 November 8->
SrivastaIndresh K |
| Soggetto topico |
Vaccines
Drug development Drug stability |
| ISBN |
1-283-17565-7
9786613175656 1-118-02363-3 1-118-02364-1 1-118-02362-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Microbial vaccines design : the reverse vaccinology approach / Roberto Rosini, Michele A. Barocchi, Rino Rappuoli -- Design and development of recombinant vaccines with viral properties / Gerd Lipowsky, Martin F. Bachmann -- Tools for vaccine design : prediction and validation of highly immunogenic and conserved class II epitopes, and development of epitope-driven vaccines / Anne S. De Groot ... [et al.] -- Virus like-particle vaccines advantages and challenges / Ted M. Ross ... [et al.] -- Design platforms of nanocapsules for human therapeutics or vaccines / Masaaki Kawano ... [et al.] -- Designing immunogens for vaccine development in reference to HIV / Aemro Kassa ... [et al.] --
Expression and purification of recombinant proteins for vaccine applications / Carlo Zambonelli, Deeann Martinez-Guzmann, and Indresh K. Srivastava -- DNA vaccines for infectious diesase / Samuel Stepenson, Manmohan Singh, Indresh K. Srivastava -- Developing stable cell lines for the production of vaccine antigens / Xiaotian Zhong ... [et al.] -- Spectroscopy of vaccines / C. Russell Middaugh, Sangeeta B. Joshi -- Biophysical characterization of protein antigens within vaccine formulations / Padima Malyala, Derek O'Hagan, Manmohan Singh -- Structural characteristics predict the stability of HIV / Zohar Biron ... [et al.] -- Selection of optimal adjuvants and product factors that affect vaccine immunogenicity / Wei Wang, Manmohan Singh -- Lyophilization and stabilization of vaccines / James Chesko ... [et al.] -- Effect of buffers and stabilizers on vaccine stability and efficacy / Shireesh P. Apte, Sydney Ugwu -- Selection of final product containers / Luis Baez, Adrian Distler -- From the lab to the clinic : filing a phase I IND for an investigational vaccine / Kenneth G. Surowitz. |
| Record Nr. | UNINA-9910139627903321 |
| Hoboken, N.J., : John Wiley & Sons, c2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Development of vaccines : from discovery to clinical testing / / edited by Manmohan Singh, Indresh K. Srivastava
| Development of vaccines : from discovery to clinical testing / / edited by Manmohan Singh, Indresh K. Srivastava |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Hoboken, N.J., : John Wiley & Sons, c2011 |
| Descrizione fisica | 1 online resource (478 p.) |
| Disciplina | 615/.372 |
| Altri autori (Persone) |
Manmohan Singh <1964 November 8->
SrivastaIndresh K |
| Soggetto topico |
Vaccines
Drug development Drug stability |
| ISBN |
9786613175656
9781283175654 1283175657 9781118023631 1118023633 9781118023648 1118023641 9781118023624 1118023625 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Microbial vaccines design : the reverse vaccinology approach / Roberto Rosini, Michele A. Barocchi, Rino Rappuoli -- Design and development of recombinant vaccines with viral properties / Gerd Lipowsky, Martin F. Bachmann -- Tools for vaccine design : prediction and validation of highly immunogenic and conserved class II epitopes, and development of epitope-driven vaccines / Anne S. De Groot ... [et al.] -- Virus like-particle vaccines advantages and challenges / Ted M. Ross ... [et al.] -- Design platforms of nanocapsules for human therapeutics or vaccines / Masaaki Kawano ... [et al.] -- Designing immunogens for vaccine development in reference to HIV / Aemro Kassa ... [et al.] --
Expression and purification of recombinant proteins for vaccine applications / Carlo Zambonelli, Deeann Martinez-Guzmann, and Indresh K. Srivastava -- DNA vaccines for infectious diesase / Samuel Stepenson, Manmohan Singh, Indresh K. Srivastava -- Developing stable cell lines for the production of vaccine antigens / Xiaotian Zhong ... [et al.] -- Spectroscopy of vaccines / C. Russell Middaugh, Sangeeta B. Joshi -- Biophysical characterization of protein antigens within vaccine formulations / Padima Malyala, Derek O'Hagan, Manmohan Singh -- Structural characteristics predict the stability of HIV / Zohar Biron ... [et al.] -- Selection of optimal adjuvants and product factors that affect vaccine immunogenicity / Wei Wang, Manmohan Singh -- Lyophilization and stabilization of vaccines / James Chesko ... [et al.] -- Effect of buffers and stabilizers on vaccine stability and efficacy / Shireesh P. Apte, Sydney Ugwu -- Selection of final product containers / Luis Baez, Adrian Distler -- From the lab to the clinic : filing a phase I IND for an investigational vaccine / Kenneth G. Surowitz. |
| Record Nr. | UNINA-9910813272203321 |
| Hoboken, N.J., : John Wiley & Sons, c2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
